K. M. Giacomini, S. Huang, D. J. Tweedie, L. Z. Benet, and K. Brouwer, Membrane transporters in drug development, Nat Rev Drug Discov, vol.9, issue.3, pp.215-236, 2010.

J. König, F. Müller, and M. Fromm, Transporters and drug-drug interactions: important determinants of drug disposition and effects, Pharmacol Rev, vol.65, issue.3, pp.944-966, 2013.

M. J. Zamek-gliszczynski, K. A. Hoffmaster, D. J. Tweedie, K. M. Giacomini, and K. M. Hillgren, Highlights from the International Transporter Consortium second workshop, Clin Pharmacol Ther, vol.92, issue.5, pp.553-556, 2012.
DOI : 10.1038/clpt.2012.126

H. Kusuhara, Imaging in the study of membrane transporters, Clin Pharmacol Ther, vol.94, issue.1, pp.33-36, 2013.

M. Muzi, D. A. Mankoff, J. M. Link, S. Shoner, and A. C. Collier, Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans, J Nucl Med, vol.50, issue.8, pp.1267-1275, 2009.

W. C. Kreisl, J. Liow, N. Kimura, N. Seneca, and S. S. Zoghbi, P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-Ndesmethyl-loperamide, J Nucl Med, vol.51, issue.4, pp.559-566, 2010.

G. Pottier, S. Marie, S. Goutal, S. Auvity, and M. Peyronneau, Imaging the impact of the Pglycoprotein (Abcb1) function on the brain kinetics of metoclopramide, J Nucl Med, vol.57, issue.2, pp.309-314, 2016.

M. Bauer, R. Karch, N. Tournier, S. Cisternino, and W. Wadsak, Assessment of P-glycoprotein transport activity at the human blood-retinal barrier with (R)-11C-verapamil PET, J Nucl Med, vol.58, issue.4, pp.678-681, 2017.

P. Kannan, C. John, S. S. Zoghbi, C. Halldin, and M. M. Gottesman, Imaging the function of Pglycoprotein with radiotracers: pharmacokinetics and in vivo applications, Clin Pharmacol Ther, vol.86, issue.4, pp.368-377, 2009.

B. Hagenbuch and B. Stieger, The SLCO (former SCL21) superfamily of transporters, Mol Aspects Med, vol.34, issue.2-3, pp.396-412, 2013.

B. Stieger and B. Hagenbuch, Organic anion-transporting polypeptides, Curr Top Membr, vol.73, pp.205-232, 2014.

M. Roth, A. Obaidat, and B. Hagenbuch, OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SCL22A gene superfamilies, Br J Pharmacol, vol.165, issue.5, pp.1260-1287, 2012.

A. Obaidat, M. Roth, and B. Hagenbuch, The expression and function of Organic Anion Transporting Polypeptides in normal tissues and in cancer, Annu Rev Pharmacol Toxicol, vol.52, pp.135-151, 2012.

B. Hagenbuch and C. Gui, Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family, Xenobiotica, vol.38, issue.7-8, pp.778-801, 2008.

A. Kalliokoski and M. Niemi, Impact of OATP transporters on pharmacokinetics, Br J Pharmacol, vol.158, issue.3, pp.693-705, 2009.

Y. Shitara, K. Maeda, K. Ikejiri, K. Yoshida, T. Horie et al., Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption, Biopharm Drug Dispos, vol.34, issue.1, pp.45-78, 2013.

X. Chu, K. Bleasby, and R. Evers, Species differences in drug transporters and implications for translating preclinical findings to humans, Expert Opin Drug Metab Toxicol, vol.9, issue.3, pp.237-52, 2013.

M. Nishimura and S. Naito, Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies, Drug Metab Pharmacokinet, vol.23, issue.1, pp.22-44, 2008.

A. Mann, I. Semenenko, M. Meir, and S. Eyal, Molecular imaging of membrane transporters' activity in cancer: a picture is worth a thousand tubes, The AAPS J, vol.17, issue.4, pp.788-801, 2015.

T. Takashima, H. Nagata, T. Nakae, Y. Cui, and Y. Wada, 20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport, J Pharmacol Exp Ther, vol.18, issue.2, pp.314-323, 2010.

T. Takashima, S. Kitamura, Y. Wada, M. Tanaka, and Y. Shigihara, PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me, J Nucl Med, vol.53, issue.5, pp.741-748, 2012.

N. Tournier, P. André, S. Blondeel, N. Rizzo-padoin, and A. Du-moulinet-d'hardemarre, Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier, J Pharm Sci, vol.98, issue.12, pp.4650-4660, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01658991

A. Shimizu, A. Kobayashi, H. Motoyama, H. Sakai, and A. Yamada, Features of acute liver congestion on gadoxetate disodium-enhanced MRI in a rat model: role of organic aniontransporting polypeptide 1a1, J. Magn Reson Imaging, vol.42, issue.3, pp.828-836, 2015.

M. Lagadec, S. Doblas, C. Giraudeau, M. Ronot, and S. A. Lambert, Advanced fibrosis: correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver, Radiology, vol.274, issue.2, pp.379-386, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02059149

T. Tsuboyama, H. Onishi, T. Kim, H. Akita, and M. Hori, Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation, Radiology, vol.255, issue.3, pp.824-833, 2010.

C. Planchamp, A. Hadengue, B. Stieger, J. Bourquin, and A. Vonlaufen, Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes, Mol Pharmacol, vol.71, issue.4, pp.1089-97, 2007.

N. Tournier, S. Goutal, S. Auvity, A. Traxl, and S. Mairinger, Strategies to inhibit ABCB1-and ABCG2-mediated efflux transport of erlotinib at the blood-brain barrier: a PET study in nonhuman primates, J Nucl Med, vol.58, issue.1, pp.117-122, 2017.

V. W. Pike, Pet radiotracers: crossing the blood-brain barrier and surviving metabolism, Trends Pharmacol Sci, vol.30, issue.8, pp.431-440, 2009.

A. Testa, M. Zanda, C. Elmore, and P. Sharma, PET tracers to study clinically relevant hepatic transporters, Mol Pharmaceutics, vol.12, issue.7, pp.2203-2216, 2015.

M. Takashima-hirano, T. Takashima, Y. Katayama, Y. Wada, and Y. Sugiyama, Efficient sequential synthesis of PET probes of the COX-2 inhibitor [11C]celecoxib and its major metabolite [11C]SC-62807 and in vivo PET evaluation, Bioorg Med Chem, vol.19, issue.9, pp.2997-3004, 2011.

S. Paulson, J. Zhang, A. Breau, J. Hribar, and N. Liu, Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats, Drug Metab Dispos, vol.28, issue.5, pp.514-521, 2000.

S. K. Paulson, J. Hribar, N. Liu, E. Hajdu, and R. Bible, Metabolism and excretion of [14C]celecoxib in healthy male volunteers, Drug Metab Dispos, vol.28, issue.3, pp.308-314, 2000.

T. Takashima, C. Wu, M. Takashima-hirano, Y. Katayama, and Y. Wada, Evaluation of breast cancer resistance protein function in hepatobiliary and renal excretion using pet with 11C-SC62807, J Nucl Med, vol.54, issue.2, pp.267-276, 2013.

H. Iimori, Y. Hashizume, M. Sasaki, Y. Kajiwara, and Y. Sugimoto, First automatic radiosynthesis of 11C labeled telmisartan using a multipurpose synthesizer for clinical research use, Ann Nucl Med, vol.25, issue.5, pp.333-337, 2011.

T. Takashima, Y. Hashizume, Y. Katayama, M. Murai, and Y. Wada, The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [11C]telmisartan, Mol Pharmaceutics, vol.8, issue.5, pp.1789-1798, 2011.

K. Shimizu, T. Takashima, T. Yamane, M. Sasaki, and H. Kageyama, Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1b3, Nucl Med Biol, vol.39, issue.6, pp.847-853, 2012.

N. Ishiguro, K. Maeda, W. Kishimoto, A. Saito, and A. Harada, Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans, Drug Metab Dispos, vol.34, issue.7, pp.1109-1115, 2006.

N. Ishiguro, K. Maeda, A. Saito, W. Kishimoto, and S. Matsushima, Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide, Drug Metab Dispos, vol.36, issue.4, pp.796-805, 2008.

A. Nishino, Y. Kato, T. Igarashi, and Y. Sugiyama, Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensinII antagonist, telmisaltan, Drug Metab. Dispos, vol.28, issue.10, pp.1146-1148, 2000.

T. Shingaki, T. Takashima, R. Ijuin, X. Zhang, and T. Onoue, Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats, J Pharmacol Exp Ther, vol.347, issue.1, pp.193-202, 2013.

R. Ijuin, T. Takashima, Y. Watanabe, Y. Sugiyama, and M. Suzuki, Synthesis of [11C]dehydropravastatin, a PET probe potentially useful for studying Oatp1b1 and Mrp2 transporters in the liver, Bioorg Med Chem, vol.20, issue.12, pp.3703-3709, 2012.

S. Kitamura, K. Maeda, Y. Wang, and Y. Sugiyama, Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin, Drug Metab Dispos, vol.36, issue.10, pp.2014-2023, 2008.

R. Ho, R. Tirona, B. Leake, H. Glaeser, and W. Lee, Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics, Gastroenterology, vol.130, issue.6, pp.1793-1806, 2006.

M. Hobbs, C. Parker, H. Birch, and K. Kenworthy, Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model, Xenobiotica, vol.42, issue.4, pp.327-338, 2012.

J. He, Y. Yu, B. Prasad, J. Link, and R. Miyaoka, Pet imaging of Oatp-mediated hepatobiliary transport of [11C]rosuvastatin in the rat, Mol Pharmaceutics, vol.11, issue.8, pp.2745-2754, 2014.

M. Hirano, K. Maeda, Y. Shitara, and Y. Sugiyama, Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans, J Pharmacol Exp Ther, vol.311, issue.1, pp.139-146, 2004.

H. Fujino, T. Saito, S. Ogawa, and J. Kojima, Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase, J Pharm Pharmacol, vol.57, issue.10, pp.1305-1311, 2005.

Y. Yagi, H. Kimura, K. Arimitsu, M. Ono, and K. Maeda, The synthesis of [18F]pitavastatin as a tracer for hOATP using the Suzuki coupling, Org Biomol Chem, vol.13, issue.4, pp.1113-1121, 2015.

H. Kimura, Y. Yagi, K. Arimitsu, K. Maeda, and K. Ikejiri, Radiosynthesis of novel pitavastatin derivative ([18F]PTV-F1) as a tracer for hepatic OATP using a one-pot synthetic procedure, J Label Compd Radiopharm, vol.59, issue.13, pp.565-575, 2016.

H. Satoh, F. Yamashita, M. Tsujimoto, H. Murakami, and N. Koyabu, Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B, Drug Metab Dispos, vol.33, issue.4, pp.518-523, 2005.

A. Koenen, K. Köck, M. Keiser, W. Siegmund, H. Kroemer et al., Steroid hormones specifically modify the activity of organic anion transporting polypeptides, Eur J Pharm Sci, vol.47, issue.4, pp.774-780, 2012.

C. Gedeon, J. Behravan, G. Koren, and M. Piquette-miller, Transport of glyburide by placental ABC transporters: implications in fetal drug exposure, Placenta, vol.27, pp.1096-1102, 2006.

L. H. Cygalova, J. Hofman, M. Ceckova, and F. Staud, Transplacental pharmacokinetics of glyburide, rhodamine 123, and bodipy FL prazosin: effect of drug efflux transporters and lipid solubility, J Pharmacol Exp Ther, vol.331, issue.3, pp.1118-1125, 2009.

L. Zhou, S. B. Naraharisetti, H. Wang, J. D. Unadkat, M. F. Hebert et al., The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an obstetric-fetal pharmacology research unit network and university of washington specialized center of research study, Mol Pharmacol, vol.73, issue.3, pp.949-959, 2008.

E. Pollex, A. Lubetsky, and G. Koren, The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta, Placenta, vol.29, issue.8, pp.743-747, 2008.

S. J. Hemauer, S. L. Patrikeeva, T. N. Nanovskaya, G. Hankins, and M. S. Ahmed, Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin, Am J Obstet Gynecol, vol.202, issue.4, pp.383-384, 2010.

N. Tournier, W. Saba, S. Cisternino, M. Peyronneau, and A. Damont, Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide, AAPS J, vol.15, issue.4, pp.1082-1090, 2013.

M. Grube, K. Köck, S. Oswald, K. Draber, and K. Meissner, Organic anion transporting polypeptide 2b1 is a high-affinity transporter for atorvastatin and is expressed in the human heart, Clin Pharmacol Ther, vol.80, issue.6, pp.607-620, 2006.

B. Stieger, J. D. Unadkat, B. Prasad, O. Langer, and H. Gali, Role of (drug) transporters in imaging in health and disease, Drug Metab Dispos, vol.42, pp.2007-2015, 2014.

A. Louie, Multimodality imaging probes: design and challenges, Chem Rev, vol.110, issue.5, pp.3146-3195, 2010.
DOI : 10.1021/cr9003538
URL : http://europepmc.org/articles/pmc2878382?pdf=render